Imaging3 hits FDA snag with 3D scanner
This article was originally published in Clinica
Executive Summary
Shares in Imaging3 plunged to almost half their value yesterday after the company said that the US FDA has rejected the 510(k) application for its flagship product, the Dominion volumetric imaging scanner.